Popular on Innoget
Publications
- View more
 | Seeking Respiratory Solutions and Technologies |
|
Our preference is to find opportunities that are on-market, market-ready, or require limited development. Opportunities may consist of new product forms, packaging innovations, delivery technologies, or new products. |
| | Seeking Solutions for Enhanced Delivery of Oral Care Actives and Flavors |
|
To improve the performance and consumer experience of oral care products using formulation excipients to improve deposition, retention and protection of actives, flavors, and sensates for extended periods |
| | Seeking Oral Care Solutions for Non-Bleach Whiteners |
|
Breakthrough whitening benefits with daily use safety profile |
 | Efficient and selective magnetic adsorbent for removal of purine compounds and nucleic acids from liquid matrices |
|
New low cost magnetic adsorbents prepared from egg-shell membranes and deep eutectic solvents, which selectively and effectively remove purine compounds and nucleic acids from liquid matrices, such as fermented drinks and/or alcoholic beverages. |
 | Ecological concretes and mortars |
|
A multidisciplinary public-private research consortium has developed a simple and innovative process to transform submerged arc welding slag waste into activated materials (geopolymers) that can be used as environmentally friendly substitutes for Portland cement to manufacture concrete or mortar-based construction materials. These new materials are characterised by low production costs, are environmentally friendly, sustainable, do not generate waste in their production process, and have excellent physico-chemical properties. Companies interested in acquiring this technology for its commercial exploitation are sought. |
 | Engineering Stem Cell-like Memory CD4+ T Cells for Enhanced Immunotherapy |
|
This invention introduces a novel method to generate stem cell-like memory T (TSCM) cells from CD4+ T cells using MEK1/2 inhibitors. These engineered TSCM cells exhibit enhanced properties including self-renewal, robust antigen-specific responses, and the ability to differentiate into various CD4+ subpopulations. This approach addresses the limitations of current T cell therapies by producing more durable and effective therapeutic cells for treating cancer, infections, and autoimmune disorders.BACKGROUND T cell therapy is a promising area in immunotherapy, but current methods face challenges such as T cell exhaustion and limited efficacy. This invention provides a solution by re-engineering CD4+ T cells into TSCM cells, offering a more robust and versatile approach to cellular immunotherapy. The technology has potential applications in various diseases, addressing the need for more effective and personalized treatments. |
Job opportunities
Introducing Innoget Jobs
Great innovation projects are built with
talented and creative people.
